Drug Information

Drug General Information
Drug ID
D07VXX
Former ID
DNC007392
Drug Name
2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528653]
Structure
Download
2D MOL

3D MOL
Formula
C13H20N2O3
Canonical SMILES
CCC(C)C(C(=O)NO)NOCC1=CC=CC=C1
InChI
1S/C13H20N2O3/c1-3-10(2)12(13(16)14-17)15-18-9-11-7-5-4-6-8-11/h4-8,10,12,15,17H,3,9H2,1-2H3,(H,14,16)
InChIKey
OISVGEVVTLNTBZ-UHFFFAOYSA-N
PubChem Compound ID
16721024
Target and Pathway
Target(s) Carbonic anhydrase IX Target Info Inhibitor [528653]
KEGG Pathway Nitrogen metabolism
Pathway Interaction Database HIF-1-alpha transcription factor network
Reactome Regulation of gene expression by Hypoxia-inducible Factor
Reversible hydration of carbon dioxide
WikiPathways Vitamin D Receptor Pathway
Reversible Hydration of Carbon Dioxide
Regulation of Hypoxia-inducible Factor (HIF) by Oxygen
References
Ref 528653Bioorg Med Chem. 2007 Mar 15;15(6):2298-311. Epub 2007 Jan 19.Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I andII with sulfonylated hydroxamates.
Ref 528653Bioorg Med Chem. 2007 Mar 15;15(6):2298-311. Epub 2007 Jan 19.Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I andII with sulfonylated hydroxamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.